Dipeptidyl peptidase 4 (DPP-4) inhibitors are a group of antihyperglycemic medications used to manage type 2 diabetes mellitus, which is a significant risk factor for coronary disease, heart failure, stroke, and many other cardiovascular conditions. This activity reviews the various drugs in this group, indications, contraindications, activity, adverse events, and other key elements of DPP-4 inhibitors therapy in the clinical setting. It also elaborates on the essential information needed by any interprofessional team member managing the care of patients with diabetes.

**Objectives:**
- Identify the mechanism of action of dipeptidyl peptidase 4 (DPP-4) inhibitors.
- Describe the potential adverse effects of dipeptidyl peptidase 4 (DPP-4) inhibitors.

- Review the appropriate monitoring of dipeptidyl peptidase 4 (DPP-4) inhibitors.
- Outline interprofessional team strategies for improving care coordination and communication to advance diabetes management and improve outcomes using DPP-4 inhibitors.